<p><strong>中国儒意控股有限公司</strong> (HKG:136) 的股东在看到股价在上个季度下跌 15% 后可能会感到担忧。另一方面，股价仍高于三年前的水平。可以说，购买指数基金可能会更划算，因为三年内 18% 的收益并不算惊人。</p>
<p>由于中国儒意控股的股东这一周表现强劲，让我们来看看长期基本面的趋势。</p>
<p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现等各个方面进行工作。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前布局。</p>
<p>引用巴菲特的话，'船只将环游世界，但平面地球协会将蓬勃发展。市场上价格与价值之间将继续存在巨大差异...' 考虑市场对公司看法变化的一种不完美但简单的方法是比较每股收益（EPS）的变化与股价变动。</p>
<p>在过去三年中，中国儒意控股未能实现每股收益的增长，反而下降了 45%（年化）。</p>
<p>这意味着市场不太可能根据盈利增长来评估公司。由于每股收益的变化似乎与股价变化无关，因此值得关注其他指标。</p>
<p>每年 40% 的收入增长可能被视为中国儒意控股正在增长的证据。如果公司是为了长期利益而管理的，那么今天的股东可能是对的，值得持有。</p>
<p>您可以在下面看到收益和收入随时间的变化（通过点击图片发现确切的数值）。</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/882017-earnings-and-revenue-growth-1-dark-2/1768261297620?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/882017-earnings-and-revenue-growth-1-dark-2/1768261297620"/></p>
<p>SEHK:136 收益和收入增长 2026 年 1 月 12 日</p>
<p>我们知道中国儒意控股最近改善了其底线，但未来会怎样呢？您可以在这个 <strong>互动</strong> 图表中查看分析师对中国儒意控股未来利润的预测。</p>
<h2>不同的视角</h2>
<p>尽管大盘在过去一年上涨了约 41%，但中国儒意控股的股东却损失了 6.0%。即使是优质股票的股价有时也会下跌，但在我们对基本面指标产生浓厚兴趣之前，我们希望看到业务的基本面有所改善。遗憾的是，去年的表现结束了一段糟糕的时期，股东在五年内面临每年 1.9% 的总损失。我们意识到巴伦·罗斯柴尔德曾说过投资者应该在 “街上有血时买入”，但我们提醒投资者首先要确保他们购买的是高质量的企业。虽然考虑市场条件对股价的不同影响是非常重要的，但还有其他因素更为重要。例如，投资风险的无处不在的阴影。<strong>我们已识别出中国儒意控股的 1 个警示信号</strong>，理解这些信号应该是您投资过程的一部分。</p>
<p>当然，<strong>中国儒意控股可能不是最佳的购买股票</strong>。因此，您可能希望查看这份 <strong>免费的</strong> 成长股集合。</p>
<p><em>请注意，本文中引用的市场回报反映了目前在香港交易所交易的股票的市场加权平均回报。</em></p>

中国儒意

<p>中国儒意控股（HKG:136）的股东在过去三年中实现了 5.5% 的年复合增长率，尽管上个季度股价下跌了 15%，每股收益下降了 45%。尽管收入年增长率达到了 40%，但该股票的表现仍落后于大盘，后者去年上涨了 41%。股东在过去五年中面临了每年 1.9% 的总损失。分析师建议因投资风险保持谨慎，并指出该公司存在一个警示信号</p>

<p><strong>China Ruyi Holdings Limited</strong> (HKG:136) shareholders might be concerned after seeing the share price drop 15% in the last quarter. On the other hand the share price is higher than it was three years ago. Arguably you'd have been better off buying an index fund, because the gain of 18% in three years isn't amazing.</p>
<div class="lb-trans"><p><strong>中国儒意控股有限公司</strong> (HKG:136) 的股东在看到股价在上个季度下跌 15% 后可能会感到担忧。另一方面，股价仍高于三年前的水平。可以说，购买指数基金可能会更划算，因为三年内 18% 的收益并不算惊人。</p>
</div><p>Since it's been a strong week for China Ruyi Holdings shareholders, let's have a look at trend of the longer term fundamentals.</p>
<div class="lb-trans"><p>由于中国儒意控股的股东这一周表现强劲，让我们来看看长期基本面的趋势。</p>
</div><p>AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.</p>
<div class="lb-trans"><p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现等各个方面进行工作。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前布局。</p>
</div><p>To quote Buffett, 'Ships will sail around the world but the Flat Earth Society will flourish. There will continue to be wide discrepancies between price and value in the marketplace...' One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.</p>
<div class="lb-trans"><p>引用巴菲特的话，'船只将环游世界，但平面地球协会将蓬勃发展。市场上价格与价值之间将继续存在巨大差异...' 考虑市场对公司看法变化的一种不完美但简单的方法是比较每股收益（EPS）的变化与股价变动。</p>
</div><p>Over the last three years, China Ruyi Holdings failed to grow earnings per share, which fell 45% (annualized).</p>
<div class="lb-trans"><p>在过去三年中，中国儒意控股未能实现每股收益的增长，反而下降了 45%（年化）。</p>
</div><p>This means it's unlikely the market is judging the company based on earnings growth. Since the change in EPS doesn't seem to correlate with the change in share price, it's worth taking a look at other metrics.</p>
<div class="lb-trans"><p>这意味着市场不太可能根据盈利增长来评估公司。由于每股收益的变化似乎与股价变化无关，因此值得关注其他指标。</p>
</div><p>It could be that the revenue growth of 40% per year is viewed as evidence that China Ruyi Holdings is growing. If the company is being managed for the long term good, today's shareholders might be right to hold on.</p>
<div class="lb-trans"><p>每年 40% 的收入增长可能被视为中国儒意控股正在增长的证据。如果公司是为了长期利益而管理的，那么今天的股东可能是对的，值得持有。</p>
</div><p>You can see below how earnings and revenue have changed over time (discover the exact values by clicking on the image).</p>
<div class="lb-trans"><p>您可以在下面看到收益和收入随时间的变化（通过点击图片发现确切的数值）。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/882017-earnings-and-revenue-growth-1-dark-2/1768261297620" alt="" original-src="https://images.simplywall.st/asset/chart/882017-earnings-and-revenue-growth-1-dark-2/1768261297620"/></p>
<p>SEHK:136 Earnings and Revenue Growth January 12th 2026</p>
<div class="lb-trans"><p>SEHK:136 收益和收入增长 2026 年 1 月 12 日</p>
</div><p>We know that China Ruyi Holdings has improved its bottom line lately, but what does the future have in store? You can see what analysts are predicting for China Ruyi Holdings in this <strong>interactive</strong> graph of future profit estimates.</p>
<div class="lb-trans"><p>我们知道中国儒意控股最近改善了其底线，但未来会怎样呢？您可以在这个 <strong>互动</strong> 图表中查看分析师对中国儒意控股未来利润的预测。</p>
</div><h2>A Different Perspective</h2>
<div class="lb-trans"><h2>不同的视角</h2>
</div><p>While the broader market gained around 41% in the last year, China Ruyi Holdings shareholders lost 6.0%. Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. Regrettably, last year's performance caps off a bad run, with the shareholders facing a total loss of 1.9% per year over five years. We realise that Baron Rothschild has said investors should &#34;buy when there is blood on the streets&#34;, but we caution that investors should first be sure they are buying a high quality business. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Consider for instance, the ever-present spectre of investment risk. <strong>We've identified 1 warning sign</strong> with China Ruyi Holdings , and understanding them should be part of your investment process.</p>
<div class="lb-trans"><p>尽管大盘在过去一年上涨了约 41%，但中国儒意控股的股东却损失了 6.0%。即使是优质股票的股价有时也会下跌，但在我们对基本面指标产生浓厚兴趣之前，我们希望看到业务的基本面有所改善。遗憾的是，去年的表现结束了一段糟糕的时期，股东在五年内面临每年 1.9% 的总损失。我们意识到巴伦·罗斯柴尔德曾说过投资者应该在 “街上有血时买入”，但我们提醒投资者首先要确保他们购买的是高质量的企业。虽然考虑市场条件对股价的不同影响是非常重要的，但还有其他因素更为重要。例如，投资风险的无处不在的阴影。<strong>我们已识别出中国儒意控股的 1 个警示信号</strong>，理解这些信号应该是您投资过程的一部分。</p>
</div><p>Of course <strong>China Ruyi Holdings may not be the best stock to buy</strong>. So you may wish to see this <strong>free</strong> collection of growth stocks.</p>
<div class="lb-trans"><p>当然，<strong>中国儒意控股可能不是最佳的购买股票</strong>。因此，您可能希望查看这份 <strong>免费的</strong> 成长股集合。</p>
</div><p><em>Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Hong Kong exchanges.</em></p>
<div class="lb-trans"><p><em>请注意，本文中引用的市场回报反映了目前在香港交易所交易的股票的市场加权平均回报。</em></p>
</div>

中国儒意控股（HKG:136）的股东在过去三年中实现了 5.5% 的年复合增长率，然而其收益却在不断缩减